Michael Freeman
Raymond James | Healthcare
Michael Freeman is an analyst from Raymond James specializing in the Healthcare sector. They are beginning to establish their track record, with 1 stock rating so far. Their current stats show a success rate of 48.72% and an average return of 0.00%.
Michael Freeman has only issued 1 rating so far. While the sample size is small, their early calls show a success rate of 48.72% and an average return of 0.00%. Investors may find their initial activity in the Healthcare sector worth watching as they build a track record.
#2493
Out of 4662
1
Total Ratings
+48.72%
Success Rate
0
Average Return
Recent Ratings Analysis
Frequency Asked Questions
Who is Michael Freeman?
Michael Freeman is an analyst from Raymond James specializing in the Healthcare sector.
What is Michael Freeman's success rate?
Michael Freeman currently has a success rate of +48.72%.
How many ratings has Michael Freeman issued?
Michael Freeman has issued 1 stock ratings so far.
What is the average return of Michael Freeman's calls?
Their stock ratings have generated an average return of 0.
What is Michael Freeman's ranking?
Michael Freeman is ranked #2493 out of 4662 analysts.
What types of ratings does Michael Freeman give?
Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.
How can I follow Michael Freeman?
You can follow Michael Freeman by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.
What is the most recent rating by Michael Freeman?
Their latest rating was a Buy on TECX issued on 2026-05-26.